was rising after the H5N1 strain of the bird flu disease was confirmed in the U.K., leading to the destruction of 159,000 turkeys in the country. BioCryst, which manufactures vaccines for the bird flu, was rising 64 cents, or 6.3%, to $10.75.
was higher by $1.07, or 2.8%, to $39.64 after Leerink Swann upgraded the stock to outperform from market perform.
plummeted 67.3% after the company said a clinical trial of a drug failed to prevent preterm births in a late-stage study. Columbia Laboratories was losing $3.10 to $1.51.
slumped another 3%, extending Friday's 3% loss. On Thursday, the company said it expects losses to widen in 2007 as it invests more in its hepatitis C drug. Vertex was losing $1 to $32.73.
Among health care stocks gaining ground,
was rising 6.6% to $5.96,
was gaining 5.2% at $2.82, and
was higher by 1% to $11.25.
As for decliners,
was sinking 3.9% to $35.71,
was shedding 1.2% to $13.32,
was off 0.8% at $48.91, and
was losing 0.8% to $54.99.